ClinConnect ClinConnect Logo
Search / Trial NCT05476523

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Launched by NEURALIGHT · Jul 25, 2022

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new software platform called NeuraLight that uses eye-tracking technology to measure eye movements. Researchers want to see how well this system can collect data from healthy individuals and compare its results to a well-established eye-tracking system. The goal is to ensure that the NeuraLight system is effective and accurate in capturing important information about how our eyes move.

If you’re between 18 and 90 years old, have normal or corrected vision, and can follow instructions, you might be eligible to participate. However, you cannot have certain conditions, like a history of epilepsy or other neurological diseases. Participants will be asked to sit calmly for about 20 minutes while the eye-tracking technology is used. This study is currently recruiting individuals, so if you or someone you know is interested in helping to improve eye movement research, this could be a great opportunity!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Men and women ages between 18 and 90 years old
  • Normal or corrected vision
  • Ability to follow instructions
  • Willing and able to sign an informed consent form
  • Exclusion Criteria:
  • Inability to sit for 20 minutes on a chair in a calm manner
  • Personal or 1st degree relative history of epilepsy
  • Additional neurological diseases
  • Drug or alcohol abuse

About Neuralight

Neuralight is a pioneering clinical trial sponsor focused on advancing innovative therapeutic solutions for neurological disorders. With a commitment to enhancing patient outcomes through cutting-edge research and development, Neuralight leverages state-of-the-art technology and a multidisciplinary approach to drive clinical trials that prioritize safety, efficacy, and patient-centric care. The organization collaborates with leading researchers, healthcare professionals, and regulatory bodies to ensure the highest standards of scientific rigor and ethical practices in its clinical investigations. Through its dedication to transforming the landscape of neurology, Neuralight aims to deliver breakthrough treatments that improve the quality of life for individuals affected by complex neurological conditions.

Locations

Wilmington, Delaware, United States

Patients applied

1 patients applied

Trial Officials

Eitan Raveh, PhD

Principal Investigator

NeuraLight

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials